Trials / Completed
CompletedNCT06470139
Dexamethasone for PENG Block in Total Hip Arthroplasty
Pericapsular Nerve Group (PENG) Block with Ropivacaine Vs Ropivacaine and Dexamethasone in Total Hip Arthroplasty: a Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Poznan University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 65 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Effect of adding Dexamethasone to Periarticular Nerve Group Block in Patients undergoing Total Hip Arthroplasty
Detailed description
Hip arthroplasty is one of the most common orthopaedic procedures, especially in elderly patients, due to the deformation of joints. Patients may complain of severe pain due to surgical trauma and prostheses. Regional anaesthesia methods may be performed to reduce the inflammatory response, opioid consumption, and opioid-related side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine 0.2% Injectable Solution | 20ml 0.2% Ropivacaine + 2.0ml 0.9% NaCl |
| DRUG | Ropivacaine 0.2% Injectable Solution + 4mg Dexamethasone | 20ml 0.2% Ropivacaine + 4mg Dexamethasone |
Timeline
- Start date
- 2024-08-13
- Primary completion
- 2025-01-15
- Completion
- 2025-02-10
- First posted
- 2024-06-24
- Last updated
- 2025-03-24
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT06470139. Inclusion in this directory is not an endorsement.